Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Reactive Arthritis: Chronic or Self-Limiting?

Michael J. Cammarata, MD  |  Issue: June 2025  |  June 8, 2025

The spondyloarthropathies encompass a group of related rheumatic diseases characterized by arthritis, enthesitis and dactylitis with variable degrees of peripheral and axial involvement. These diseases include radiographic and nonradiographic axial spondyloarthritis, psoriatic arthritis, undifferentiated peripheral spondyloarthritis, inflammatory bowel disease-associated arthritis (i.e., enteropathic arthritis) and reactive arthritis (see Figure 1).13

Figure 1. Click to enlarge.

Alexis Ogdie, MD, MSCE, associate professor of medicine and associate professor of epidemiology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, as well as an expert in spondyloarthritis, estimates she has seen only a few cases of reactive arthritis among a larger cohort of patients with spondyloarthritis, which is reflected in the rarity of reactive arthritis represented in previously published spondyloarthritis registries.14

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

With no validated diagnostic criteria, a diagnosis of reactive arthritis is based on clinical factors. The most widely used criteria for reactive arthritis were proposed by the ACR in 1999 and Braun et al. in 2000.7 The more recent Assessment of SpondyloArthritis International Society (ASAS) classification criteria for spondyloarthritis do not formally include reactive arthritis; however, the classification criteria for peripheral spondyloarthritis include preceding infection.15

Clinical Presentation

Reactive arthritis usually presents as an acute, asymmetric oligoarthritis one to two weeks after onset of a gastrointestinal or genitourinary infection, but can occur up to four weeks after infection with Chlamydia trachomatis.5 Common precipitating organisms include gut bacteria, such as Yersinia, Salmonella, Shigella and Campylobacter, and urogenital tract organisms, such as Chlamydia, Ureaplasma and Mycoplasma. Additional culprit organisms are highlighted in Table 1.5

Click to enlarge.

At disease onset, analysis of synovial fluid can help exclude septic arthritis. Synovial fluid will be inflammatory, with 2,000–64,000 white blood cells, but synovial cultures will be negative.5 Evidence of preceding infection should be sought, although no definite recommended laboratory testing has been established, and often the precipitating infection may go undetected due to lack of symptoms. In fact, a prior infection is identified in only 60% of patients clinically diagnosed with reactive arthritis.16

John Miller, MD, assistant professor of medicine at the Johns Hopkins Arthritis Center, Baltimore, says “the clinical presentation (e.g., diarrhea, hematochezia, dysuria) will often guide the evaluation for infectious etiology. This usually includes stool or urine cultures and nucleic acid testing; however, many other pathogens have been implicated in reactive arthritis (e.g., Giardia, Strongyloides, Clostridium difficile), so additional testing may be necessary, depending on the initial symptoms.”

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:Axial SpondyloarthritisConditions Tagged with:biologic DMARDsdisease managementextra-articular manifestationsGlucocorticoidsHLA-B27infectious etiologymusculoskeletal manifestationsNSAIDsReactive arthritisspondyloarthritissulfasalazine

Related Articles

    Top Research in Axial Spondyloarthritis Presented at ACR Convergence 2022

    November 18, 2022

    PHILADELPHIA—Approximately 100 research abstracts on axial spondyloarthritis (axSpA) were accepted for presentation at ACR Convergence 2022. It is exciting to see a wealth of research on axSpA being undertaken worldwide. Here, we highlight important points from 10 of these studies. 1. Abstract 0378: Prevalence of Axial Spondyloarthritis (axSpA) in Patients Treated for Chronic Back Pain…

    Rheumatologists Make Progress Defining Spectrum of Axial Spondyloarthritis

    May 1, 2014

    New research clarifies terminology used for diagnosis, but questions remain around epidemiology, genetics and management of patients with axial skeletal inflammation

    Nelosa/shutterstock.com

    Men, Women & Medical Differences in Axial Spondyloarthropathy

    October 24, 2019

    Historically, ankylosing spondylitis was considered mainly a male disease. But it has become evident this predominance is not as great as previously believed. Here we discuss recent developments in the area, including potential differences between the sexes in symptom and disease burden, immunological and genetic background, diagnostic delay, treatment response and ongoing research questions. Medical…

    Key Research in Axial Spondyloarthritis Encapsulated

    December 2, 2024

    Our understanding of (axSpA) has really changed, especially with regard to male-female differences. In this report, we identify important research on axSpA presented at ACR Convergence 2024, summarize the abstracts and comment on why each is important, addressing the relevance for clinicians and the potential impact on future research.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences